Hao, Qi https://orcid.org/0000-0001-6246-2153
Rathinaswamy, Manoj K.
Klinge, Kelly L.
Bratkowski, Matthew https://orcid.org/0000-0003-3911-0533
Mafi, Amirhossein
Baumgartner, Christina K.
Hamel, Keith M.
Veits, Gesine K.
Jain, Rinku
Catalano, Claudio https://orcid.org/0000-0002-2437-6235
Fitzgerald, Mark
Hird, Alexander W.
Park, Eunice
Vora, Harit U.
Henderson, James A.
Longenecker, Kenton
Hutchins, Charles W.
Qiu, Wei
Scapin, Giovanna
Sun, Qi
Stoll, Vincent S.
Sun, Chaohong
Li, Ping
Eaton, Dan https://orcid.org/0000-0003-3933-0958
Stokoe, David
Fisher, Stewart L.
Nasveschuk, Christopher G. https://orcid.org/0000-0003-4671-6939
Paddock, Marcia
Kort, Michael E.
Article History
Received: 4 January 2024
Accepted: 30 July 2024
First Online: 16 August 2024
Competing interests
: Q.H., M.K.R., A.M., M.B., D.S., D.E., and M.P. are employees of Calico Life Sciences, LLC. K.L.K., C.K.B., K.M.H., R.J., K.L., C.W.H., W.Q., Q.S., V.S.S., C.S, and M.E.K. are employees of AbbVie. G.K.V., M.F., A.W.H, E.P., H.U.V. J.A.H., P.L., S.F. and C.G.N. are previous or current employees of C4 therapeutics. C.C. and G.S. are employees of Nanoimaging.
: AbbVie is committed to humane care and use of laboratory animals. The animal study was reviewed and approved by AbbVie’s IACUC and in compliance with the NIH Guide for Care and Use of Laboratory Animals guidelines. The animal study was conducted in an AAALAC-accredited manner ensuring veterinary care and oversight was provided. AbbVie utilized 8- to 12-week-old female C57BL/6 N mice obtained from Charles Rivers Laboratories. Per the IACUC protocol, the maximal bodyweight loss allowable for each animal was ≥20%, which would warrant humane euthanasia. In most cases during our studies at Abbvie, any animal with 15% loss in body weight was euthanized and removed from study.